Multi-trait growth helps regenerate blood cells

Scientists from Duke University Medical Center, in the United States, have confirmed that multi-characteristic growth factors can promote the expansion and regeneration of hematopoietic stem cells.

The results of this study have great potential in the field of regenerative medicine.

In the study's results published in the latest issue of the journal 'Nature-Medicine', scientists say, for those who need stem cell transplantation, the umbilical cord is the source of hematopoietic stem cells. most popular.

However, the number of umbilical cord stem cells is often limited, so it is important to study methods that can accelerate the growth of umbilical stem cell growth.

Scientists have introduced a multi-trait growth factor into the experimental mice whose growth marrow is inhibited by radiation. The results showed that the growth rate of marrow stem cells of rats was 10 times higher than that of mice not included in the multi-characteristic growth factor.

In hematopoiesis in the laboratory, a multi-trait growth factor has been confirmed to promote growth of umbilical stem cells. In addition, scientists have demonstrated that multi-characteristic growth factors will not cause mice to get cancer.

The scientists also said that treatment with the advantage of multi-trait growth factor is important to increase blood capacity and restore the immune system for patients undergoing chemotherapy. treatment or radiation therapy.

However, scientists still need to experiment many times on animals to be able to conduct clinical experiments.

Currently, scientists are gradually implementing experiments to prove whether multi-trait growth factors can play an important role in the growth and development of universal stem cells. /.